<< Read Full Article
<< Read Full Article
Updated from 3:19 9.m. EDT
And at $95, Roche and Genentech(DNA Quote) said, "Done deal."
The Swiss drug giant and its smaller, yet arguably more valuable northern California biotech cousin finally agreed to terms early Thursday on a takeover deal that has hogged the attention of health care investors since last summer.
Roche agreed to purchase the remaining 44% of Genentech it doesn't already own for $95 a share - a final price that met with the approval of Genentech's board. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.00 | 1,107.93 | 2,201.05 | 36.03 |
Oil *
72.08
|
|
DOWN
49.05
|
DOWN
6.18
|
DOWN
11.05
|
UP
0.57
|
10 Yr
3.60%
SPDR Gold
110.21
|
|
-0.47%
|
-0.55%
|
-0.50%
|
+1.61%
|
Data delayed 20 minutes |
Connect with TheStreet